Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
anti-sense oligo
Biotech
Lilly pens $13M upfront oligonucleotide AI pact with Creyon Bio
Lilly is paying $13 million upfront for the opportunity to develop AI-designed oligonucleotide therapies from Creyon Bio.
Ben Adams
Apr 29, 2025 10:07am
After 11-month romance, GSK buys oligonucleotide partner Elsie
Jun 6, 2024 9:41am
Creyon collects $40M to create 'on demand' RNA-based medicines
Mar 8, 2022 10:00am
BMS, VCs back Ceptur with $75M for RNA meds to silence pre-mRNA
Jan 19, 2022 7:00am
Takeda crashes out of Wave discovery pact at cost of $23M
Oct 20, 2021 8:10am
PepGen raises $113M to challenge Sarepta in DMD
Aug 5, 2021 7:00am
